The FDA has approved a treatment option for adults with multidrug resistant HIV infection, marking a “new class of antiretroviral medications” for this patient population.
New findings published in HIV Medicine have shed light on distinct risks, clinical characteristics, and outcomes at the time of HIV diagnosis among Canadian patients younger than vs older than age 50...
The US Food and Drug Administration approved a drug for the treatment of HIV-1 infection in conjunction with other antiretroviral therapies among children aged at least 4 weeks who weigh at least 3 kg. ...
The Centers for Disease Control and Prevention has released guidance on what to consider when evaluating adolescents for pre-exposure prophylaxis for the prevention of HIV.
Although nonalcoholic fatty liver disease is known to be a major cause of liver disease in people with HIV infection, much is still unclear about which of these patients are more likely to develop more...
While frailty and sarcopenia have been linked to abdominal obesity and its related comorbidities, the effect of these conditions on non-alcoholic fatty liver disease in individuals with HIV infection is not...
While it is well established that NAFLD is associated with CVD in the general population, the association among individuals living with HIV is less well understood.
The model required community-based pharmacists and HIV medical providers to share patient clinical information, identify therapy-related problems, and develop therapy-related action plans. Learn more about...
